2005•Journal of Medical ForumRequires access

Combination of Transcatheter Arterial Chemoembolization and Cool-tip Radiofrequency Ablation in Treating Advanced Hepatocellular Carcinoma

Huanzhou Xue

Abstract

Objective To evaluate the clinical effect of radiofrequency ablation (RFA) combined with transcatheter arterial chemoemblization (TACE)in treating advanced primary hepatocellular carcinoma. Methods 126 cases with unresectary advanced primary hepatocellular carcinoma were selected for observation from March 2002 to November 2004, 115 cases were treated with RFA after TACE, and regularly examine the value of AFP ,B-ultrasound or CT .11 caces were treated with RFA 1~2weeks before TACE .Results All of caces were well treated with RFA and TACE , 121 cases were followed up ,5 cases lost follow-up,survival time 4~5months. Mean survival time was (8± 3.1 )months , no death or severe complications. Conclusion RFA combined with TACE is an effective method for treating advanced primary hepatocellular carcinoma.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Hepatocellular carcinoma, Radiofrequency ablation, Transcatheter arterial chemoembolization, Radiology, Carcinoma, Ablation, Surgery